BSN and epilepsy: Arginase deficiency has previously been shown to promote tissue lipid accumulation via enhanced de novo lipogenesis independent of systemic metabolic changes [15], suggesting that BSN mutations may drive a cholesterol–arginase imbalance as a mechanistic contributor to epilepsy.